Date published: 2026-2-3

1-800-457-3801

SCBT Portrait Logo
Seach Input

LONRF1 Inhibitors

LONRF1, short for "LON Peptidase N-Terminal Domain and Ring Finger 1," is a multifunctional protein that plays a role in various cellular processes, including protein quality control, regulation of apoptosis, and response to cellular stress. It is part of the LON family of proteins, which are conserved ATP-dependent proteases.The LONRF1 protein contains a Lon protease N-terminal domain and a RING finger domain. The Lon domain suggests a role in the selective degradation of misfolded, damaged, or regulatory proteins, a critical function in maintaining cellular homeostasis. The RING finger domain is typically associated with E3 ubiquitin ligase activity, implying a role in tagging proteins with ubiquitin for subsequent degradation by the proteasome.

LONRF1's involvement in protein quality control means it is integral to the cell's response to stressors that cause protein damage, such as oxidative stress or heat shock. By helping to clear misfolded or damaged proteins, LONRF1 contributes to the protection of cells from the toxic effects of protein aggregation.In the context of apoptosis, or programmed cell death, LONRF1 may have a regulatory function. It can interact with other proteins involved in the apoptotic pathway to modulate cell death signals, which is crucial in development, immune system functioning, and cancer suppression.The diverse functions of LONRF1 reflect the importance of fine-tuned protein regulation in cellular physiology. Disruptions in the expression or activity of LONRF1 could have significant consequences, potentially leading to disorders associated with protein aggregation, such as neurodegenerative diseases, or affecting the cell's ability to control its life cycle, which is a critical aspect of cancer biology.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$60.00
$265.00
$1000.00
163
(3)

Proteasome inhibitor, may impact protein degradation pathways relevant to LONRF1.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$135.00
$1085.00
115
(2)

Proteasome inhibitor, potentially influencing proteolytic processes involving LONRF1.

Lactacystin

133343-34-7sc-3575
sc-3575A
200 µg
1 mg
$188.00
$575.00
60
(2)

Specific proteasome inhibitor, could affect protein turnover related to LONRF1 function.

Carfilzomib

868540-17-4sc-396755
5 mg
$41.00
(0)

Irreversible proteasome inhibitor, potentially impacting LONRF1-associated pathways.

Epoxomicin

134381-21-8sc-201298C
sc-201298
sc-201298A
sc-201298B
50 µg
100 µg
250 µg
500 µg
$137.00
$219.00
$449.00
$506.00
19
(2)

Selective and irreversible proteasome inhibitor, may influence LONRF1 function.

Oprozomib

935888-69-0sc-477447
2.5 mg
$280.00
(0)

Proteasome inhibitor, could indirectly modulate pathways involving LONRF1.

Ixazomib

1072833-77-2sc-489103
sc-489103A
10 mg
50 mg
$311.00
$719.00
(0)

Proteasome inhibitor, may affect proteolytic activities related to LONRF1.

Mithramycin A

18378-89-7sc-200909
1 mg
$55.00
6
(1)

Inhibits DNA binding of transcription factors, potentially affecting transcription regulation by LONRF1.

Triptolide

38748-32-2sc-200122
sc-200122A
1 mg
5 mg
$90.00
$204.00
13
(1)

Inhibits transcriptional activity, could indirectly influence LONRF1's role in transcription regulation.

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$74.00
$243.00
$731.00
$2572.00
$21848.00
53
(3)

Inhibits RNA polymerase, potentially affecting transcription processes involving LONRF1.